Critical Pharmacodynamic Warning

isoflurane affects the 2E1 metabolic pathway.

When patients take isoflurane concurrently with drugs metabolized by 2E1, the risk of adverse effects may significantly increase. This interaction affects drug clearance and systemic exposure, potentially leading to toxicity or reduced therapeutic efficacy.

Clinical Impact: As a under review, isoflurane can alter the metabolism of substrate drugs, requiring careful monitoring and potential dose adjustments.

Clinical Overview for isoflurane

This page outlines known interaction pathways involving isoflurane, focusing primarily on its profile as a under review affecting the 2E1 pathway.

Enzyme Interaction Profile

isoflurane demonstrates under review potency against 2E1. Clinical significance of this interaction requires further evaluation.

Inhibitor

A substance that slows down or prevents an enzyme from metabolizing a drug. Inhibitors can lead to increased drug concentrations in the body, potentially causing toxicity or enhanced therapeutic effects.

Clinical Example: isoflurane affects 2E1

Inducer

A substance that speeds up enzyme activity, causing drugs to be cleared from the body faster. Inducers can reduce drug effectiveness by lowering concentrations below therapeutic levels.

Known Inducers: ethanol
Interaction Details
Drug Name isoflurane
Affected Enzyme 2E1
Inhibitor Strength under review Under Evaluation
Inducers ethanol
Inhibitors diethyl-dithiocarbamate
Clinical Recommendations

Clinical significance pending review. Exercise caution.

Monitoring Parameters:
  • Therapeutic drug levels
  • Adverse effect monitoring
  • Clinical response assessment
Dose Considerations:
  • Consider dose reduction
  • Evaluate alternative therapies
  • Adjust based on response
Quick Facts
Interaction ID
3158
Primary Pathway
2E1
Interaction Type
Enzyme Inhibition
Clinical Phase
Under Evaluation
Clinical Significance

Clinical significance requires further evaluation.

Information Sources
  • FDA Drug Interaction Database
  • Clinical Pharmacology Guidelines
  • Pharmaceutical Labeling Information
  • Published Clinical Studies
Last updated: June 16, 2026
Back Return to Database